Solu Therapeutics Announces Presentation of Trial in Progress on STX-0712 for Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting

Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that it will present ...
IEEE

Wheat Leaf Disease Identification Based on a Fusion Model Integrating Attention Mechanisms and Channel-Spatial Reconstruction Convolution

Abstract: With the continuous growth in food demand and the escalating importance of crop health, the challenges posed by the high costs and low efficiency of traditional wheat leaf disease detection ...
Live Science

Diagnostic dilemma: Woman had her twin brother's XY chromosomes — but only in her blood

Doctors discovered a woman had "blood chimerism" after examining the chromosomes of cells from different parts of her body.
The Lancet

Trends in major non-communicable diseases and related risk factors in China 2002–2019: an analysis of nationally representative survey data

Current smokers were those who were still smoking at the time of the survey. Excessive drinking referred to the drinking behavior of male drinkers with an average daily alcohol intake of greater than ...
Hosted on MSN

Chimera Investment Q3 earnings miss as REIT prepared for acquisition

Chimera Investment (CIM) Q3 earnings missed the Wall Street consensus, with the quarter marking a transition for the company as it moved to cash ahead of its HomeXpress acquisition, the company said ...
Yahoo Finance

Chimera: Q3 Earnings Snapshot

NEW YORK (AP) — NEW YORK (AP) — Chimera Investment Corp. (CIM) on Thursday reported a loss of $580,000 in its third quarter. On a per-share basis, the New York-based company said it had a loss of 27 ...